Tag Archives: Research and development

Q&A With Renee Tannenbaum

By Brittany Agro | Published: November 20, 2009
One major theme at the HBA leadership conference may be simple for industry to understand but difficult to accept: change or drown. But for Renee Tannenbaum, it was change that worked toward her advantage. And change, combined with her desire to drive improvement in patient care and meet unmet needs, is what led her to [...]
Posted in Events, Strategy | Also tagged , , , , , , , | Leave a comment

The Case for Specialty Medicines: Is Industry Credible, or Culpable?

By William Looney | Published: November 11, 2009
What’s so special about specialty? This was the question lurking below the surface in many of the presentations at a conference hosted by Pharm Exec’s sister organization, CBI, in Philadelphia last week. Now that the blockbuster era is fading under a wave of patent expirations, big pharma is pinning its hopes on the specialty category [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

Roche: New Hires Needed

By Brittany Agro | Published: November 11, 2009
Cheer up, pharma, not all the news is bad! Amidst the worst national job market since the early 1980’s, Roche Pharma Research in Nutley, NJ is looking to hire. Efforts are currently underway to find scientists and support staff in areas such as screening, safety, and bioanalytics. In addition to inflammation, the Nutley operation serves as [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

Abbott to Purchase Solvay for $6.6 Billion (Update 1)

By George Koroneos | Published: September 28, 2009
Abbott announced, early Monday morning, that it had signed a deal to purchase Belgium-based drug manufacturer Solvay Pharmaceuticals for $6.6 billion in cash—a mere five months after Solvay’s CEO Werner Cautreels announced that the company was searching for a proper suitor. The deal adds more than $3 billion in annualized sales to its global pharmaceutical business—three-quarters [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

Q&A with Steven Paul: Lilly’s New Development Plan

By George Koroneos | Published: September 23, 2009
Last week, Lilly announced a major restructuring plan focused around the creation of one Developmental Center of Excellence and several individual business units. The media (Pharm Exec included) focused on the news that 5,500 jobs were being cut as part of the plan. This week, we’re talking to Lilly to find out what the company’s [...]
Posted in Strategy | Also tagged , , , , , , | 3 Comments